GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioage Labs Inc (NAS:BIOA) » Definitions » Cash Flow from Others

BIOA (Bioage Labs) Cash Flow from Others : $1.27 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Bioage Labs Cash Flow from Others?

Bioage Labs's cash flow from others for the three months ended in Dec. 2024 was $-0.36 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2024 was $1.27 Mil.


Bioage Labs Cash Flow from Others Historical Data

The historical data trend for Bioage Labs's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioage Labs Cash Flow from Others Chart

Bioage Labs Annual Data
Trend Dec22 Dec23 Dec24
Cash Flow from Others
0.08 16.60 1.26

Bioage Labs Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only 7.12 1.14 0.13 0.36 -0.36

Bioage Labs Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.27 Mil.

Bioage Labs Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Bioage Labs's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioage Labs Business Description

Traded in Other Exchanges
Address
1445A South 50th Street, Richmond, CA, USA, 94804
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.

Bioage Labs Headlines

From GuruFocus